-
Stable MS Patients Who Switch Interferon Therapy at Higher Risk of Flares, Study Reports
Multiple sclerosis (MS) patients who have been relapse-free while using an interferon-beta (IFN-β) therapy but switch to another IFN-β are significantly more like to start experiencing flares than patients who remain on their initial interferon treatment, a real-world study reports. Read more about this story here.
Are you interested in following this story?
Sorry, there were no replies found.
Log in to reply.